| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 65373-29-7 | MS21570 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 16078-42-5 | MS2126 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 1255516-86-9 | MS-1020 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 129716-45-6 | MS-073 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 1197196-63-6 | MS0124 |
≥98% | | 询价 |
| 6 | 2089617-83-2 | MS012 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 691392-89-9 | MS-0022 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 124285-22-9 | MS0019266 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 21945-37-9 | MS0017509 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 73912-52-4 | MS0015203 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 872122-36-6 | MRZ-8676 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 1359944-60-7 | MRT-83 HCl salt |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 405221-09-2 | MRT80 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 34604-52-9 | Ms-PEG3-Ms |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 1312309-62-8 | Ms-PEG2-t-butyl ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 1820968-63-5 | MSP3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 289902-82-5 | MSK-195 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 137668-62-3 | Msh(5-10),cyclic |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 97-54-1 | Isoeugenol |
≥98% | | 询价 |
| 20 | 1408064-71-0 | JNK-IN-7 |
≥98% | | 询价 |
| 21 | 1704741-11-6 | AZ-PFKFB3-67 |
≥98% | | 询价 |
| 22 | 1704740-52-2 | AZ-PFKFB3-26 |
≥98% | | 询价 |
| 23 | 615539-20-3 | AZP-2006 free base |
≥98% | | 询价 |
| 24 | 1644545-52-7 | Vorasidenib(AG-881) |
| | 询价 |
| 25 | 1429176-69-1 | Mutant IDH1 inhibitor 2 |
| | 询价 |
| 26 | 1355326-21-4 | Mutant IDH1 inhibitor 1 |
| | 询价 |
| 27 | 1429180-08-4 | Mutant IDH1 inhibitor |
| | 询价 |
| 28 | 1448347-49-6 | Ivosidenib(AG-120AG 120AG120) |
| | 询价 |
| 29 | 1628805-46-8 | IDH-305 |
| | 询价 |
| 30 | 1616671-13-6 | AZP-2006 disulfate |
≥98% | | 询价 |
| 31 | 1088543-62-7 | AZP 531 |
≥98% | | 询价 |
| 32 | 495-48-7 | Azoxybenzene |
≥98% | | 询价 |
| 33 | 138926-19-9 | Ibandronate sodium |
≥98% | | 询价 |
| 34 | 22204-48-4 | Azotomycin monosodium |
≥98% | | 询价 |
| 35 | 174008-52-7 | ML 10375 |
≥98% | | 询价 |
| 36 | 7644-67-9 | Azotomycin |
≥98% | | 询价 |
| 37 | 51-40-1 | Norepinephrine bitartrate |
≥98% | | 询价 |
| 38 | 5834-96-8 | Azothoate |
≥98% | | 询价 |
| 39 | 37091-66-0 | Azlocillin |
≥98% | | 询价 |
| 40 | 6491-83-4 | Methyl leucylleucinate HCl |
≥98% | | 询价 |
| 41 | 503-74-2 | Isovaleric acid |
≥98% | | 询价 |
| 42 | 1370706-59-4 | CL-55 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 120162-55-2 | Azimsulfuron |
≥98% | | 询价 |
| 44 | 1824707-75-6 | Azilsartan trimethylethanolamine(TAK-491) |
≥98% | | 询价 |
| 45 | | Azilsartan sodium |
≥98% | | 询价 |
| 46 | 77741-79-8 | Azidowarfarin |
≥98% | | 询价 |
| 47 | 2054345-67-2 | azido-tris(ethylenoxy)-L-alanine TFA Salt |
≥98% | | 询价 |
| 48 | 870487-48-2 | Ms-PEG4-t-butyl ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 2109805-78-7 | MU-380 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 5819-62-5 | m-Toluidine,alpha-(methylsulfonyl)-4-propoxy- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 5819-77-2 | m-Toluidine,alpha-((p-chlorophenyl)sulfonyl)-4-(octyloxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 5819-64-7 | m-Toluidine,alpha-(methylsulfonyl)-4-(pentyloxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 5819-67-0 | m-Toluidine,alpha-(methylsulfonyl)-4-(nonyloxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | 5819-66-9 | m-Toluidine,alpha-(methylsulfonyl)-4-octyloxy- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 5819-61-4 | m-Toluidine,alpha-(methylsulfinyl)-4-(octyloxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 5804-05-7 | m-Toluidine,alpha-methoxy-4-(octyloxy)-,hydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 5804-10-4 | m-Toluidine,alpha-(4-amino-2-methoxyphenoxy)-4-(octyloxy)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 5819-78-3 | m-Toluidine,4-(octyloxy)-alpha-(p-tolylsulfonyl)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 5819-56-7 | m-Toluidine,4-(octyloxy)-alpha-(propylthio)-,hydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 5819-60-3 | m-Toluidine,4-(octyloxy)-alpha-(phenylthio)-,methanesulfonate |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com